19337474

Source:http://linkedlifedata.com/resource/pubmed/id/19337474

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0087111, umls-concept:C0730285, umls-concept:C0796392, umls-concept:C1517572, umls-concept:C1656863
pubmed:issue	1
pubmed:dateCreated	2009-4-1
pubmed:abstractText	To evaluate the effect of intravitreal bevacizumab on visual function and retinal thickness in patients with diabetic macular edema (DME).
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-10568703, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-11527957, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-11755841, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-11931788, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-11986098, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-12488256, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-12523885, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-14985312, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-15136787, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-15294883, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-15936441, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16154196, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16156152, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16186374, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16205561, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16458968, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16508423, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16508424, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16508425, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16508426, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-16508427, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-17151486, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-17398322, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-17601433, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-2866759, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-6379946, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-7526212, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-7943121, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-8366922, http://linkedlifedata.com/resource/pubmed/commentcorrection/19337474-9732337
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8804513
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized, http://linkedlifedata.com/resource/pubmed/chemical/Vascular Endothelial Growth Factor A, http://linkedlifedata.com/resource/pubmed/chemical/bevacizumab
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	1011-8942
pubmed:author	pubmed-author:ParkIn WonIW, pubmed-author:SeoJeong WonJW
pubmed:issnType	Print
pubmed:volume	23
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	17-22
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:19337474-Angiogenesis Inhibitors, pubmed-meshheading:19337474-Antibodies, Monoclonal, pubmed-meshheading:19337474-Antibodies, Monoclonal, Humanized, pubmed-meshheading:19337474-Diabetic Retinopathy, pubmed-meshheading:19337474-Female, pubmed-meshheading:19337474-Follow-Up Studies, pubmed-meshheading:19337474-Humans, pubmed-meshheading:19337474-Injections, pubmed-meshheading:19337474-Laser Therapy, pubmed-meshheading:19337474-Macular Edema, pubmed-meshheading:19337474-Male, pubmed-meshheading:19337474-Middle Aged, pubmed-meshheading:19337474-Retrospective Studies, pubmed-meshheading:19337474-Time Factors, pubmed-meshheading:19337474-Tomography, Optical Coherence, pubmed-meshheading:19337474-Treatment Outcome, pubmed-meshheading:19337474-Vascular Endothelial Growth Factor A, pubmed-meshheading:19337474-Visual Acuity, pubmed-meshheading:19337474-Vitrectomy, pubmed-meshheading:19337474-Vitreous Body
pubmed:year	2009
pubmed:articleTitle	Intravitreal bevacizumab for treatment of diabetic macular edema.
pubmed:affiliation	Department of Ophthalmology, Hallym University College of Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
pubmed:publicationType	Journal Article, Comparative Study